Viatris Inc (VTRS)
Viatris is a healthcare company. Co.'s portfolio comprises of approved molecules across a range of therapeutic areas, including brands, generic, complex generic and biosimilars. From cardiovascular health to oncology, Co. provides treatment options across therapeutic areas covering a variety of non-communicable and infectious diseases. Co. also provides support services such as diagnostic clinics, educational seminars and digital tools. Co. provides a range of treatment options across all its therapeutic areas, with several categories containing several products in a range of dosage forms, formulations and delivery systems that allow physicians to tailor care for optimal treatment.
VTRS SEC Filing Email Alerts Service
| Company Name: |
Viatris Inc |
| Website: |
www.viatris.com |
| Sector: |
Drugs & Pharmaceuticals |
| Number of ETFs Holding VTRS: |
104 |
| Total Market Value Held by ETFs: |
$2.50B |
| Total Market Capitalization: |
$13.21B |
| % of Market Cap. Held by ETFs: |
18.94% |
|
|
April 19, 2024 • 6:28 AM Eastern
Hold (1.50 out of 4)
100th percentile
|
|
Free VTRS Email Alerts:
